NP
NextCell Pharma Stock: price and insider trades · Sweden
ISIN SE0009723125SE·
No insider purchase over the last 90 days. The latest, by Leo Cornelis Groenewegen, was filed 28 Dec 2017.
NextCell Pharma: what insiders have been doing
Insider filings for NextCell Pharma are scarce in the Finansinspektionen feed, the latest one published on 28 December 2017. This page will fill in as new trades are disclosed. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€9,080
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 28 December 2017
Declarations3 total
- 15,000 shares@ SEK 6.00100.0% of flowISIN SE0009723125FI:csv-1a2a0ee9674a1b5f612cCanonical exit: 27 Mar 2018 (T+90)
- 96,000 shares0FI:csv-162b2ec3655de0f7fe50
- 120,000 shares@ SEK 25.00100.0% of flowFI:csv-0941ab4c69e153e4312e
3 of 3 declarations
About NextCell Pharma
NextCell Pharma is a biopharmaceutical company focused on developing cell therapies for the treatment of type 1 diabetes. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations